Release Date: 01/02/24 16:16 Summary: Takeover - extension of offer period Price Sensitive: Yes Download Document 543.82KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%